|
🐜
|
Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
24 auth.
A. Puel,
Sophie Cypowyj,
J. Bustamante,
Jill F. Wright,
Luyan Liu,
H. Lim,
M. Migaud,
L. Israel,
M. Chrabieh,
Magali Audry,
...
Matthew Gumbleton,
A. Toulon,
C. Bodemer,
Jamila El-Baghdadi,
M. Whitters,
T. Paradis,
J. Brooks,
M. Collins,
N. Wolfman,
S. Al‐Muhsen,
M. Galicchio,
L. Abel,
C. Picard,
J. Casanova
|
9 |
2011 |
9
🐜
|
|
🐜
|
Therapeutic Potential of SH2 Domain-Containing Inositol-5′-Phosphatase 1 (SHIP1) and SHIP2 Inhibition in Cancer
10 auth.
G. Fuhler,
R. Brooks,
B. Toms,
S. Iyer,
Elizabeth A Gengo,
Mi-Young Park,
...
Matthew Gumbleton,
Dennis R. Viernes,
J. Chisholm,
W. Kerr
|
6 |
2012 |
6
🐜
|
|
🦁
|
SHIP1 Intrinsically Regulates NK Cell Signaling and Education, Resulting in Tolerance of an MHC Class I–Mismatched Bone Marrow Graft in Mice
Matthew Gumbleton,
É. Vivier,
W. Kerr
|
5 |
2015 |
5
🦁
|
|
🦁
|
Dual enhancement of T and NK cell function by pulsatile inhibition of SHIP1 improves antitumor immunity and survival
7 auth.
Matthew Gumbleton,
R. Sudan,
Sandra Fernandes,
R. Engelman,
Christopher M. Russo,
J. Chisholm,
...
W. Kerr
|
5 |
2017 |
5
🦁
|
|
🦁
|
Role of inositol phospholipid signaling in natural killer cell biology
Matthew Gumbleton,
W. Kerr
|
5 |
2013 |
5
🦁
|
|
🐬
|
SHIP1-expressing mesenchymal stem cells regulate hematopoietic stem cell homeostasis and lineage commitment during aging.
S. Iyer,
R. Brooks,
Matthew Gumbleton,
W. Kerr
|
4 |
2015 |
4
🐬
|
|
🐜
|
Therapeutic Potential of SH 2 Domain-Containing Inositol-5 ′-Phosphatase 1 ( SHIP 1 ) and SHIP 2 Inhibition in Cancer
10 auth.
G. Fuhler,
R. Brooks,
B. Toms,
S. Iyer,
Elizabeth A Gengo,
Mi-Young Park,
...
Matthew Gumbleton,
Dennis R. Viernes,
J. Chisholm,
W. Kerr
|
3 |
2012 |
3
🐜
|
|
🐜
|
SHIPi Enhances Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
8 auth.
Sandra Fernandes,
R. Brooks,
Matthew Gumbleton,
Mi-Young Park,
Christopher M. Russo,
Kyle T. Howard,
...
J. Chisholm,
W. Kerr
|
3 |
2015 |
3
🐜
|
|
🦁
|
TTF-1 and immune checkpoint therapy in non-small cell lung cancer
Matthew Gumbleton,
E. Snyder
|
1 |
2023 |
1
🦁
|
|
🐜
|
Abstract C81: Therapeutic potential of SHIP1 and SHIP2 inhibitors in cancer.
8 auth.
W. Kerr,
R. Brooks,
Mi-Young Park,
Matthew Gumbleton,
S. Iyer,
Dennis R. Viernes,
...
J. Chisholm,
G. Fuhler
|
0 |
2011 |
0
🐜
|
